S-EPMC9073799 - Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer. - OmicsDI

Unknown

Dataset Information

Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer.

ABSTRACT:

SUBMITTER: Maltoni R

PROVIDER: S-EPMC9073799 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sorry, this publication's infomation has not been loaded in the Indexer, please go directly to PUBMED or Altmetric.

Similar Datasets